Remdesivir-associated bradycardia in COVID-19: a rapid review protocol

INTRODUCTION: Remdesivir is an antiviral medication that is used in the treatment of severe COVID-19. Research has highlighted the potential cardiac side effects of remdesivir, including the occurrence of remdesivir-associated bradycardia (RAB), but these findings have not been consistent. In additi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Elli, Cosme, Celica, Bauzon, Justin, Batra, Kavita, Azar, Fadi, Schreiber, Ariyon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254952/
https://www.ncbi.nlm.nih.gov/pubmed/37258075
http://dx.doi.org/10.1136/bmjopen-2022-068564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254952/
https://www.ncbi.nlm.nih.gov/pubmed/37258075
http://dx.doi.org/10.1136/bmjopen-2022-068564

Ejemplares similares